My sibling sent me a couple of TikToks with folks talking up Pyxis Oncology… Anyone have any thoughts on this one?
What I know…
just under 2 years of cash burn runway
2 drugs (or more?) with INDs submitted
1 starting Phase 1 trials (many many drugs never get past Phase 1 or 2)
Obviously high risk high reward in an $81M company…
Buyout potential…?
Thanks!
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
They dosed their first patient just about a week ago, though I’d guess that it’s the promotional attention really driving the shares at this point. $200 million now. I don’t like to speculate on early stage biotechs, especially those that are getting a lot of hype before trial results are in, but I sure hope the drug works.